The upregulation of VCAM-1 on inflamed colonic vessels and colorectal tumour vasculature, coupled with its involvement in immune cell infiltration and cancer cell metastasis, has highlighted it as an attractive candidate for receptor-mediated imaging and drug delivery systems in colorectal disease. This evidence concerns the gene VCAM1 and cancer.